Keyphrases
Scotland
100%
Clinical Practice
100%
Atrial Fibrillation
100%
Comparative Effectiveness
100%
Direct Oral Anticoagulants
100%
Comparative Safety
100%
Rivaroxaban
100%
Apixaban
83%
All-cause Mortality
33%
Myocardial Infarction
33%
Dabigatran
33%
Pulmonary Embolism
33%
Systemic Embolism
33%
High Risk
16%
Hazard Ratio
16%
Bleeding
16%
Retrospective Cohort Study
16%
Cox Proportional Hazards Model
16%
Clinical Efficacy
16%
Cardiovascular Mortality
16%
Stroke Risk
16%
Mortality Event
16%
Routine Clinical Practice
16%
Major Bleed
16%
High Bleeding Risk
16%
Linked Administrative Data
16%
Bleeding Events
16%
Clinical Safety
16%
Preventing Stroke
16%
Gastrointestinal Bleeding
16%
Oral Anticoagulant Therapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Rivaroxaban
100%
Atrial Fibrillation
100%
Direct Oral Anticoagulant
100%
Apixaban
83%
Bleeding
33%
All Cause Mortality
33%
Heart Infarction
33%
Ciclonicate
33%
Lung Embolism
33%
Dabigatran
33%
Cohort Study
16%
Thromboembolism
16%
Population Study
16%